Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Ono Pharmaceutical (4528 JP)
Watchlist
89
Analysis
Health Care
•
Japan
ONO PHARMACEUTICAL CO., LTD. manufactures and sells pharmaceuticals. The Company mainly researches and develops prescription drugs.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Ono Pharmaceutical
•
11 May 2018 19:02
Ono FY17 Earnings - First Glance
Ono Pharmaceutical Co Ltd (4528 JP) reported FY17 results on May 10, 2018 Opdivo led FY17 topline growth and gross margins expansion in line with...
Dion Stéfan Büchner M.D., FCAP
88 Views
Share
bullish
•
Ono Pharmaceutical
•
18 Apr 2018 19:24
Ono’s Stock Price Decline on Merck’s KN-189 Success
On April 16, 2018, the topline data for Ono Pharmaceutical Co Ltd (4528 JP) Opdivo and Merck & Co. Inc. (MRK US) Keytruda, both as a...
Dion Stéfan Büchner M.D., FCAP
125 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Apr 2018 17:33
Japan Pharmaceuticals: The Week that Was…
Takeda Pharmaceutical Co Ltd (4502 JP) @ ¥ 4,911/ share (down 24% YTD) implies ~17x (~30% discount to industry average) our FY19e core EPS of ¥...
Dion Stéfan Büchner M.D., FCAP
110 Views
Share
bullish
•
Ono Pharmaceutical
•
12 Apr 2018 18:18
Ono’s Stock Price Decline on Merck’s KN-042 Success
Merck & Co. (NYSE: MRK), on April 09, 2018, announced Keytruda’s (pembrolizumab) success in improving overall survival (OS) as 1L treatment in...
Dion Stéfan Büchner M.D., FCAP
118 Views
Share
bullish
•
Thematic (Sector/Industry)
•
03 Apr 2018 15:41
Japan Pharma - Drug Price Revision in April 2018
Japan, after the US and China, is the world’s third largest pharma industry, worth ~$70b in 2016. However, according to research and consulting...
Dion Stéfan Büchner M.D., FCAP
249 Views
Share
First
Previous
8
9
10
11
12
13
14
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x